Clinical trials for a COVID-19 vaccine being developed by AstraZeneca, a UK-Swedish drug firm, and Oxford University, are set to resume. The trials were suspended after a participant fell ill
Clinical trials for a COVID-19 vaccine being developed by AstraZeneca, a UK-Swedish drug firm, and Oxford University, are set to resume. The trials were suspended after a participant fell ill